Page 3 - Severity Score News Today

HMO supplementation may boost bowel function and help adults with IBS: Study Supplementation with the human milk oligosaccharides (HMOs) HMOs 2-fucosyllactose (2FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study. Five grams per day of 2FL and LNnT in a 4:1 mass ratio for 12 weeks led to significant improvements in the number of bowel movements with abnormal stool consistency, the IBS Symp...

HMO supplementation may boost bowel function and help adults with IBS: Study Supplementation with the human milk oligosaccharides (HMOs) HMOs 2-fucosyllactose (2FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study. Five grams per day of 2FL and LNnT in a 4:1 mass ratio for 12 weeks led to significant improvements in the number of bowel movements with abnormal stool consistency, the IBS Symp...

email article An investigative, add-on MDMA-based therapy was effective for improving posttraumatic stress disorder (PTSD) symptoms, according to a phase III trial. In a randomized controlled trial of 90 adults with severe chronic PTSD, those on MDMA pharmacotherapy plus psychotherapy saw a significant improvement in PTSD symptoms as measured by the clinician-administered CAPS-5 Total Severity Score versus those on placebo and psychotherapy alone ( d=0.91, 95% CI 0.44-1.37, P

Integrating Deep Learning CT-scan Model Helps Predict Severity of COVID-19 Patients Study finds significantly improved prognosis performance that when comparing AI-severity with 11 existing severity scores; AI-severity can therefore rapidly become a reference scoring approach Kaplan–Meier curves for the high-risk individuals and the ones with low or medium risk according to AI-severity. The threshold to assign individuals into a high-risk group was the 2/3 quantile of the AI-severity score c...

 E-Mail Paris, France, January 27th 2021 -- COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections. Owkin, a French-American startup pioneering AI and Federated Learning in medical research, has been focusing its COVID-19 research efforts on aspects of the pandemic that still require much public health attention, despite the arrival of an effective vaccine. Efforts to support frontline health systems as they dev...